Ollagnier M - Search Results

1

[French pharmacovigilance database system: examples of utilisation].

Moore N, Noblet C, Kreft-Jais C, Lagier G, Ollagnier M, Imbs JL. Moore N, et al. Among authors: ollagnier m. Therapie. 1995 Nov-Dec;50(6):557-62. Therapie. 1995. PMID: 8745956 French.

2

[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].

Auriche M, Bertrand P, Blay N, Danan G, Hamel JD, Imbs JL, Lagier G, Micaleff A, Moore N, Ollagnier M, Reveilleau-Richard S, Soubrié C, Weber F. Auriche M, et al. Among authors: ollagnier m. Therapie. 1997 Mar-Apr;52(2):123-7. Therapie. 1997. PMID: 9231506 French.

3

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.

Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, Bégaud B. Moore N, et al. Among authors: ollagnier m. Br J Clin Pharmacol. 1997 Nov;44(5):513-8. doi: 10.1046/j.1365-2125.1997.00615.x. Br J Clin Pharmacol. 1997. PMID: 9384470 Free PMC article.

4

[Drug-induced taste disorders: analysis of the French Pharmacovigilance Database and literature review].

Ratrema M, Guy C, Nelva A, Benedetti C, Beyens MN, Grasset L, Ollagnier M; Association Française des Centres Régionaux de Pharmacovigilance. Ratrema M, et al. Among authors: ollagnier m. Therapie. 2001 Jan-Feb;56(1):41-50. Therapie. 2001. PMID: 11322016 Review. French.

5

[Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].

Benedetti-Bardet C, Guy C, Boudignat O, Regnier-Zerbib A, Ollagnier M; Centres Régionaux de Pharmacovigilance. Benedetti-Bardet C, et al. Among authors: ollagnier m. Therapie. 2001 May-Jun;56(3):295-9. Therapie. 2001. PMID: 11475811 French.

6

[Fever caused by fipexide. Evaluation of the national pharmacovigilance survey].

Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Guy C, et al. Among authors: ollagnier m. Therapie. 1990 Sep-Oct;45(5):429-31. Therapie. 1990. PMID: 2260037 French.

7

Cough and ACE inhibitors.

Moore N, Noblet C, Joannidès R, Ollagnier M, Imbs JL, Lagier G. Moore N, et al. Among authors: ollagnier m. Lancet. 1993 Jan 2;341(8836):61. doi: 10.1016/0140-6736(93)92543-3. Lancet. 1993. PMID: 8093315 No abstract available.

8

[Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of a eight-year French national survey].

Mounier G, Guy C, Berthoux F, Beyens MN, Ratrema M, Ollagnier M. Mounier G, et al. Among authors: ollagnier m. Therapie. 2006 May-Jun;61(3):255-66. Therapie. 2006. PMID: 16989128 French.

9

[Adverse effects of quinine in the treatment of leg cramps].

Beyens MN, Guy C, Ollagnier M. Beyens MN, et al. Among authors: ollagnier m. Therapie. 1999 Jan-Feb;54(1):59-62. Therapie. 1999. PMID: 10216424 French.

10

[Dextropropoxyphene hepatotoxicity: four cases and literature review].

Bergeron L, Guy C, Ratrema M, Beyens MN, Mounier G, Ollagnier M. Bergeron L, et al. Among authors: ollagnier m. Therapie. 2002 Sep-Oct;57(5):464-72. Therapie. 2002. PMID: 12611201 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters